What are the major opportunities in the Tuberculosis Diagnostics market? What are the strategies for the Tuberculosis Diagnostics market?

For detailed insights on the major opportunities and strategies in the Tuberculosis Diagnostics market, Read More

How does the Tuberculosis Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Tuberculosis Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Tuberculosis Diagnostics market growth? SWOT analysis of the Tuberculosis Diagnostics market.

For detailed insights on the key dynamics influencing the Tuberculosis Diagnostics market growth and SWOT analysis of the Tuberculosis Diagnostics industry, Read More

Tuberculosis Diagnostics Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Tuberculosis Diagnostics Market Report 2026

Name: Tuberculosis Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Test Type (Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types), By Disease Stage (Latent Tuberculosis, Active Tuberculosis), By End-User (Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tuberculosis Diagnostics Market Overview

• Tuberculosis Diagnostics market size has reached to $2.34 billion in 2025

• Expected to grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%

• Growth Driver: Rise In Incidence Of Tuberculosis Driving Market Growth Due To Increased Need For Early Detection And Accurate Diagnosis

• Market Trend: Product Innovations Driving Tuberculosis Diagnostics

• Asia-Pacific was the largest region in 2025.

What Is Covered Under Tuberculosis Diagnostics Market?

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

The various types of tuberculosis diagnostic markets include radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test or Mantoux test (TST), blood/serology test, smear microscopy tests, cell culture-based tests, and others. Radiographic tests are used to detect chest abnormalities in the case of tuberculosis symptoms. The radiographic test refers to the diagnosis of lesions that may develop anywhere in the lungs and vary in terms of cavitation, density, size, and shape. The tests include nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and others, used for disease stages such as latent tuberculosis and active tuberculosis. The end-users of tuberculosis diagnostics include hospitals and diagnostic laboratories, physician’s office laboratories, reference laboratories, academic institutions, and research facilities.

Tuberculosis Diagnostics market report bar graph

What Is The Tuberculosis Diagnostics Market Size and Share 2026?

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.34 billion in 2025 to $2.52 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to global tuberculosis disease burden, expansion of public health screening programs, availability of smear microscopy infrastructure, international funding for tb control, adoption of culture-based diagnostics.

What Is The Tuberculosis Diagnostics Market Growth Forecast?

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for rapid and accurate tb diagnosis, rising focus on drug-resistant tb detection, expansion of decentralized diagnostic testing, increasing investments in molecular diagnostics, integration of ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of molecular tb testing methods, rising use of rapid diagnostic platforms, growing integration of drug resistance detection, expansion of point-of-care tb testing, enhanced focus on high-sensitivity diagnostics.

Book your 30 minutes free consultation with our research experts

Global Tuberculosis Diagnostics Market Segmentation

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

What Is The Driver Of The Tuberculosis Diagnostics Market?

The rise in the incidence of tuberculosis is driving the demand for the tuberculosis diagnostics market going forward. Tuberculosis (TB) is a contagious bacterial infection primarily affecting the lungs which requires timely detection to prevent severe complications and transmission. The rise in the incidence of tuberculosis (TB) is due to the increasing prevalence of HIV/AIDS, which severely compromises the immune system and makes individuals highly susceptible to developing active tuberculosis disease. The increase in the incidence of tuberculosis supports the tuberculosis diagnostics by boosting demand for rapid, accurate, and point-of-care diagnostic tests that enable early treatment initiation and better disease management. For instance, in October 2025, according to the UK Health Security Agency, a government agency responsible for all health security in England, Tuberculosis levels in England increased by 13.6 percent in 2024 compared with 2023, with 5,490 notifications reported in 2024 compared to 4,831 in 2023. Therefore, the rise in the incidence of tuberculosis is driving the growth of the tuberculosis diagnostics industry.

Key Players In The Global Tuberculosis Diagnostics Market

Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio

Global Tuberculosis Diagnostics Market Trends and Insights

Major companies operating in the tuberculosis diagnostics market are focusing on product innovations and developing new product solutions, such as tuberculosis diagnostic tests, to strengthen their position in the market. Tuberculosis diagnostic tests refer to medical examinations and laboratory techniques used to detect whether a person is infected with Mycobacterium tuberculosis, the bacteria that cause TB. These tests help identify active TB disease, latent TB infection, and drug-resistant strains so that appropriate treatment can begin promptly. For example, in February 2023, Redcliffe Labs, an India-based technology-empowered diagnostics service provider, launched the BD MAX MDR TB (Tuberculosis) test, a diagnostic test to enable clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test, which is performed on BD MAX molecular diagnostic system. Clinicians use the test to simultaneously detect bacteria that cause TB and determine if the bacteria contain mutations associated with resistance to two important first-line drugs, Isoniazid (INH) and Rifampicin (RIF).

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Tuberculosis Diagnostics Market?

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc, foran undisclosed amount. With this acquisition, Danaher Corporation seeks to strengthen its position in the life sciences sector by leveraging Abcam plc's extensive portfolio of high-quality reagents and antibodies, thereby enhancing its capabilities in scientific research and development to better serve the growing demand for advanced biological research tools. Abcam plc isa UK-based biotechnology company that offers tuberculosis diagnostics.

Regional Outlook

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Tuberculosis Diagnostics Market?

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Tuberculosis Diagnostics Market Report 2026?

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Tuberculosis Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.52 billion
Revenue Forecast In 2035	$3.37 billion
Growth Rate	CAGR of 7.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Test Type, Disease Stage, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Tuberculosis Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Tuberculosis Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Tuberculosis Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Tuberculosis Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Adoption Of Molecular Tb Testing Methods

4.2.2 Rising Use Of Rapid Diagnostic Platforms

4.2.3 Growing Integration Of Drug Resistance Detection

4.2.4 Expansion Of Point-Of-Care Tb Testing

4.2.5 Enhanced Focus On High-Sensitivity Diagnostics

5. Tuberculosis Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Diagnostic Laboratories

5.2 Reference Laboratories

5.3 Public Health Institutions

5.4 Physician’S Office Laboratories

5.5 Research Institutes

6. Tuberculosis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tuberculosis Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Tuberculosis Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tuberculosis Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tuberculosis Diagnostics Market Segmentation

9.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

9.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Latent Tuberculosis, Active Tuberculosis

9.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

9.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chest X-rays, CT Scans

9.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

9.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interferon Gamma Release Assays (IGRAs)

9.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

GeneXpert MTB/RIF, Line Probe Assays

9.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tuberculin Skin Test (TST)

9.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Serological Tests for Antibodies

9.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acid-Fast Bacilli (AFB) Smear Test

9.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Solid Media Cultures, Liquid Media Cultures

9.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Molecular Tests, Advanced Imaging Techniques

10. Tuberculosis Diagnostics Market Regional And Country Analysis

10.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tuberculosis Diagnostics Market

11.1. Asia-Pacific Tuberculosis Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tuberculosis Diagnostics Market

12.1. China Tuberculosis Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tuberculosis Diagnostics Market

13.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tuberculosis Diagnostics Market

14.1. Japan Tuberculosis Diagnostics Market Overview

14.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tuberculosis Diagnostics Market

15.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tuberculosis Diagnostics Market

16.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tuberculosis Diagnostics Market

17.1. South Korea Tuberculosis Diagnostics Market Overview

17.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tuberculosis Diagnostics Market

18.1. Taiwan Tuberculosis Diagnostics Market Overview

18.2. Taiwan Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tuberculosis Diagnostics Market

19.1. South East Asia Tuberculosis Diagnostics Market Overview

19.2. South East Asia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tuberculosis Diagnostics Market

20.1. Western Europe Tuberculosis Diagnostics Market Overview

20.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tuberculosis Diagnostics Market

21.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tuberculosis Diagnostics Market

22.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tuberculosis Diagnostics Market

23.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tuberculosis Diagnostics Market

24.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tuberculosis Diagnostics Market

25.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tuberculosis Diagnostics Market

26.1. Eastern Europe Tuberculosis Diagnostics Market Overview

26.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tuberculosis Diagnostics Market

27.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tuberculosis Diagnostics Market

28.1. North America Tuberculosis Diagnostics Market Overview

28.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tuberculosis Diagnostics Market

29.1. USA Tuberculosis Diagnostics Market Overview

29.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tuberculosis Diagnostics Market

30.1. Canada Tuberculosis Diagnostics Market Overview

30.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tuberculosis Diagnostics Market

31.1. South America Tuberculosis Diagnostics Market Overview

31.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tuberculosis Diagnostics Market

32.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tuberculosis Diagnostics Market

33.1. Middle East Tuberculosis Diagnostics Market Overview

33.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tuberculosis Diagnostics Market

34.1. Africa Tuberculosis Diagnostics Market Overview

34.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tuberculosis Diagnostics Market Regulatory and Investment Landscape

36. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

36.1. Tuberculosis Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Tuberculosis Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Tuberculosis Diagnostics Market Company Profiles

36.3.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis

36.3.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Tuberculosis Diagnostics Market Other Major And Innovative Companies

PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt. Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc

38. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

40. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Tuberculosis Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Tuberculosis Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Tuberculosis Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Tuberculosis Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Tuberculosis Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Tuberculosis Diagnostics Market, Supply Chain Analysis

Table 4: Global Tuberculosis Diagnostics Market, Major Raw Material Providers

Table 5: Global Tuberculosis Diagnostics Market, Major Resource Providers

Table 6: Global Tuberculosis Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Tuberculosis Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Tuberculosis Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Tuberculosis Diagnostics Market, Major Trends

Table 10: Global Tuberculosis Diagnostics Market, Major End Users

Table 11: Global Tuberculosis Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Tuberculosis Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Tuberculosis Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Tuberculosis Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: China, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: India, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Japan, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Australia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Indonesia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South Korea, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Taiwan, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: South East Asia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Western Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: UK, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Germany, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: France, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Italy, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Spain, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Russia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: North America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: USA, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Canada, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: South America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Brazil, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Middle East, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Africa, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 101: Global Tuberculosis Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 102: Global Tuberculosis Diagnostics Market - Company Scoring Matrix

Table 103: Beckton, Dickinson and Company Financial Performance

Table 104: F. Hoffmann-La Roche Ltd Financial Performance

Table 105: Qiagen N.V Financial Performance

Table 106: BioMerieux SA Financial Performance

Table 107: Danaher Corporation Financial Performance

Table 108: Global Tuberculosis Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 109: Global Tuberculosis Diagnostics Market, Competitive Dashboard

Table 110: Global Tuberculosis Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 111: Global, Tuberculosis Diagnostics Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Table 112: Global, Tuberculosis Diagnostics Market Size Gain ($ Billion), Segmentation By Disease Stage, 2025 – 2030

Table 113: Global, Tuberculosis Diagnostics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Tuberculosis Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Tuberculosis Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Tuberculosis Diagnostics Market, Supply Chain Analysis

Figure 4: Global Tuberculosis Diagnostics Market, Major Raw Material Providers

Figure 5: Global Tuberculosis Diagnostics Market, Major Resource Providers

Figure 6: Global Tuberculosis Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Tuberculosis Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Tuberculosis Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Tuberculosis Diagnostics Market, Major Trends

Figure 10: Global Tuberculosis Diagnostics Market, Major End Users

Figure 11: Global Tuberculosis Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Tuberculosis Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Tuberculosis Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Tuberculosis Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: China, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: India, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Japan, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Australia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Indonesia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South Korea, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Taiwan, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: South East Asia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Western Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: UK, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Germany, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: France, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Italy, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Spain, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Russia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: North America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: USA, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Canada, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: South America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Brazil, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Middle East, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Africa, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 101: Global Tuberculosis Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 102: Global Tuberculosis Diagnostics Market - Company Scoring Matrix

Figure 103: Beckton, Dickinson and Company Financial Performance

Figure 104: F. Hoffmann-La Roche Ltd Financial Performance

Figure 105: Qiagen N.V Financial Performance

Figure 106: BioMerieux SA Financial Performance

Figure 107: Danaher Corporation Financial Performance

Figure 108: Global Tuberculosis Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 109: Global Tuberculosis Diagnostics Market, Competitive Dashboard

Figure 110: Global Tuberculosis Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 111: Global, Tuberculosis Diagnostics Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Figure 112: Global, Tuberculosis Diagnostics Market Size Gain ($ Billion), Segmentation By Disease Stage, 2025 – 2030

Figure 113: Global, Tuberculosis Diagnostics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

The global medical gloves market report offers strategic insights and market intelligence through 2025.

Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Aircraft Sensors Market Report 2026 - Global Outlook – By Sensor Type (Temperature, Pressure, Position, Flow, Torque, Radar, Accelerometer, Proximity), By Aircraft Type (Narrow-Body Aircraft, Wide-Body Aircraft, Very Lar...

Medical And Diagnostic Laboratory Services Market Report 2026 - Global Outlook – By Type (Diagnostic Imaging Centers, Medical Laboratory Services), By Type of Expenditure (Public, Private), By Application (Cardiology, On...

Allogeneic T Cell Therapies Market Report 2026 - Global Outlook – By Product Type (Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies), By Antigen Type (CD 19, CD 20, Egfrvlll, GD2, CD22, C...

Hospital Acquired Infections Testing Kits Market Report 2026 - Global Outlook – By Product (Consumables And Reagents, Instruments), By Test Type (Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infec...

Dental Adhesives And Sealants Market Report 2026 - Global Outlook – By Product (Adhesives, Sealants), By Etching Type (Self-Etching Adhesive, Total Etching Adhesive, Other Etching Types), By Formulation (Water-Based, Sol...

Merkel Cell Carcinoma Treatment Market Report 2026 - Global Outlook – By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), By Therapy (Surgical Excision, Micrographic Surgery, Radiation, Chemotherapy,...

Frequently Asked Questions

How big is the Tuberculosis Diagnostics Market?

The Tuberculosis Diagnostics market was valued at $2.34 billion in 2025, increased to $2.52 billion in 2026, and is projected to reach $3.37 billion by 2030.

What is the Tuberculosis Diagnostics market growth?

The global Tuberculosis Diagnostics market is expected to grow at a CAGR of 7.5% from 2026 to 2035 to reach $3.37 billion by 2035.

Who are the key players in Tuberculosis Diagnostics market?

Some Key Players in the Tuberculosis Diagnostics market Include, Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Bi

Major trend in this market includes: Product Innovations Driving Tuberculosis Diagnostics. For further insights on this market. request a sample here

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, M

Book your 30 minutes free consultation with our research experts

Contact Us